182 related articles for article (PubMed ID: 3014039)
1. Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis.
Nepom BS; Palmer J; Kim SJ; Hansen JA; Holbeck SL; Nepom GT
J Exp Med; 1986 Jul; 164(1):345-50. PubMed ID: 3014039
[TBL] [Abstract][Full Text] [Related]
2. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
3. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals.
Henson V; Maclaren N; Riley W; Wakeland EK
Immunogenetics; 1987; 25(3):152-60. PubMed ID: 2881884
[TBL] [Abstract][Full Text] [Related]
5. Immunogenetics of disease susceptibility: new perspectives in HLA.
Nepom GT; Seyfried CA; Nepom BS
Pathol Immunopathol Res; 1986; 5(1):37-46. PubMed ID: 3774753
[TBL] [Abstract][Full Text] [Related]
6. A deletion mutant defines DQ beta variants with DR4 positive DQw3 positive haplotypes.
Nepom BS; Kim SJ; Nepom GT
Hum Immunol; 1986 Oct; 17(2):87-93. PubMed ID: 2875977
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus.
Monos DS; Mickelson E; Hansen JA; Baker L; Zmijewski CM; Kamoun M
Hum Immunol; 1988 Dec; 23(4):289-99. PubMed ID: 3266208
[TBL] [Abstract][Full Text] [Related]
8. Identification of an HLA-DQ beta-chain related genomic sequence associated with insulin-dependent diabetes.
Michelsen B; Kastern W; Lernmark A; Owerbach D
Biomed Biochim Acta; 1985; 44(1):33-6. PubMed ID: 2986612
[TBL] [Abstract][Full Text] [Related]
9. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
Robinson DM; Holbeck S; Palmer J; Nepom GT
Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM.
Erlich HA; Bugawan TL; Scharf S; Nepom GT; Tait B; Griffith RL
Diabetes; 1990 Jan; 39(1):96-103. PubMed ID: 2210066
[TBL] [Abstract][Full Text] [Related]
11. Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.
Tilanus MG; Morolli B; van Eggermond MC; Schreuder GM; de Vries RR; Giphart MJ
Immunogenetics; 1986; 23(5):333-40. PubMed ID: 3011659
[TBL] [Abstract][Full Text] [Related]
12. HLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.
Gogolin KJ; Spielman RS
Genet Epidemiol; 1989; 6(1):113-6. PubMed ID: 2567253
[TBL] [Abstract][Full Text] [Related]
13. HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation.
Monos DS; Spielman RS; Gogolin KJ; Radka SF; Baker L; Zmijewski CM; Kamoun M
Immunogenetics; 1987; 26(4-5):299-303. PubMed ID: 2888728
[No Abstract] [Full Text] [Related]
14. Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ beta-chain gene.
Kim SJ; Holbeck SL; Nisperos B; Hansen JA; Maeda H; Nepom GT
Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8139-43. PubMed ID: 2999795
[TBL] [Abstract][Full Text] [Related]
15. Determinants of genetic susceptibility in HLA-associated autoimmune disease.
Nepom GT
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S53-62. PubMed ID: 2791347
[TBL] [Abstract][Full Text] [Related]
16. T-cell-defined DR4 subtypes as markers for type 1 diabetes.
Rowe JR; Mickelson EM; Hansen JA; MacDonald MJ; Allen CI; Gabbay KH; Yunis EJ; Sheehy MJ
Hum Immunol; 1988 May; 22(1):51-60. PubMed ID: 3260586
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis for HLA class II associations with rheumatoid arthritis.
Nepom GT; Hansen JA; Nepom BS
J Clin Immunol; 1987 Jan; 7(1):1-7. PubMed ID: 3558732
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the HLA-DQ3.2 insulin-dependent diabetes mellitus susceptibility gene.
Kwok WW; Lotshaw C; Milner EC; Knitter-Jack N; Nepom GT
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1027-30. PubMed ID: 2783780
[TBL] [Abstract][Full Text] [Related]
19. DR4 and susceptibility to type I diabetes mellitus: discrimination of high risk and low risk DR4 haplotypes on the basis of TA10 typing.
Tait BD; Boyle AJ
Tissue Antigens; 1986 Aug; 28(2):65-71. PubMed ID: 3489301
[TBL] [Abstract][Full Text] [Related]
20. Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus.
Rønningen KS; Undlien DE; Ploski R; Maouni N; Konrad RJ; Jensen E; Hornes E; Reijonen H; Colonna M; Monos DS
Eur J Immunol; 1993 May; 23(5):1050-6. PubMed ID: 8477801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
